{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:03:24Z","timestamp":1780632204082,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T00:00:00Z","timestamp":1196294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T00:00:00Z","timestamp":1196294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.jhh.1002310","type":"journal-article","created":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T11:56:58Z","timestamp":1196337418000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus"],"prefix":"10.1038","volume":"22","author":[{"given":"M E","family":"Marketou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E A","family":"Zacharis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Koukouraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M I","family":"Stathaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Arfanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G E","family":"Kochiadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Chlouverakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N S","family":"Karkavitsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P E","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,29]]},"reference":[{"key":"BF1002310_CR1","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/01.CIR.103.12.1618","volume":"103","author":"JA Beckman","year":"2001","unstructured":"Beckman JA, Goldfine AB, Gordon MB, Creager MA . Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001; 103: 1618\u20131623.","journal-title":"Circulation"},{"key":"BF1002310_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC . Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813\u2013882.","journal-title":"Diabetes Care"},{"key":"BF1002310_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2796.2000.00654.x","volume":"247","author":"P Libby","year":"2000","unstructured":"Libby P . Changing concepts of atherogenesis. J Intern Med 2000; 247: 349\u2013358.","journal-title":"J Intern Med"},{"key":"BF1002310_CR4","first-page":"1380","volume":"14","author":"RH Straub","year":"2000","unstructured":"Straub RH, Linde H, Mannel DN, Scholmerich J, Falk W . A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-\u03b1 and IL-6 secretion in the spleen. FASEB J 2000; 14: 1380\u20131388.","journal-title":"FASEB J"},{"key":"BF1002310_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/10715769809069280","volume":"28","author":"CA Opere","year":"1998","unstructured":"Opere CA, Opere D, Ohia SE . Mechanism of peroxide-induced potentiation of sympathetic neurotransmission in bovine irides: role of extracellular calcium. Free Radic Res 1998; 28: 283\u2013292.","journal-title":"Free Radic Res"},{"key":"BF1002310_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145\u2013153.","journal-title":"N Engl J Med"},{"key":"BF1002310_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjhyper.2003.08.005","volume":"17","author":"G Yasuda","year":"2004","unstructured":"Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S et al. Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy. Am J Hypertens 2004; 17: 14\u201320.","journal-title":"Am J Hypertens"},{"key":"BF1002310_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.amjhyper.2004.08.014","volume":"18","author":"AJ Manolis","year":"2005","unstructured":"Manolis AJ, Iraklianou S, Pittaras A, Zairis M, Tsioufis K, Psaltiras G et al. Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy. Am J Hypertens 2005; 18: 18\u201322.","journal-title":"Am J Hypertens"},{"key":"BF1002310_CR9","unstructured":"World Health Organization Study Group. Diabetes Mellitus, Technical report series no. 727 Geneva: World Health Organization, 1985."},{"key":"BF1002310_CR10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Stampfer MJ, Hennekens CH . Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767\u20131772.","journal-title":"Circulation"},{"key":"BF1002310_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/clc.4960241103","volume":"24","author":"U Ikeda","year":"2001","unstructured":"Ikeda U, Ito T, Shimada K . Interleukin-6 and acute coronary syndrome. Clin Cardiol 2001; 24: 701\u2013704.","journal-title":"Clin Cardiol"},{"key":"BF1002310_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-3-4","volume":"3","author":"RU Pliquett","year":"2004","unstructured":"Pliquett RU, Fasshauer M, Bluher M, Paschke R . Neurohumoral stimulation in type-2-diabetes as an emerging disease concept. Cardiovasc Diabetol 2004; 3: 4.","journal-title":"Cardiovasc Diabetol"},{"key":"BF1002310_CR13","first-page":"559","volume":"33","author":"DJ Paulson","year":"1981","unstructured":"Paulson DJ, Light KE . Elevation of serum and ventricular norepinephrine content in the diabetic rat. Res Commun Chem Pathol Pharmacol 1981; 33: 559\u2013562.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BF1002310_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1056-8727(97)00015-9","volume":"5","author":"O Schnell","year":"1997","unstructured":"Schnell O, Muhr D, Weiss M, Kirsch C, Haslbeck M, Tatsch K et al. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. J Diab Complications 1997; 5: 307\u2013313.","journal-title":"J Diab Complications"},{"key":"BF1002310_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nuclcard.2005.11.009","volume":"13","author":"S Nagamachi","year":"2006","unstructured":"Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non\u2013insulin-dependent diabetes mellitus. J Nucl Cardiol 2006; 13: 34\u201342.","journal-title":"J Nucl Cardiol"},{"key":"BF1002310_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00259-003-1388-6","volume":"31","author":"B Hesse","year":"2004","unstructured":"Hesse B, Meyer C, Nielsen FS, Sato A, Hove JD, Holm S et al. Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition. Eur J Nucl Med Mol Imaging 2004; 31: 362\u2013368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF1002310_CR17","doi-asserted-by":"publisher","first-page":"25C","DOI":"10.1016\/S0002-9149(01)01539-9","volume":"87","author":"D Weiss","year":"2001","unstructured":"Weiss D, Sorescu Taylor WR . Angiotensin II and atherosclerosis. Am J Cardiol 2001; 87: 25C\u201332C.","journal-title":"Am J Cardiol"},{"key":"BF1002310_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","volume":"42","author":"KK Koh","year":"2003","unstructured":"Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, Shin MS et al. Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 2003; 42: 905\u2013910.","journal-title":"J Am Coll Cardiol"},{"key":"BF1002310_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0021-9150(03)00158-8","volume":"169","author":"T Takeda","year":"2003","unstructured":"Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, Hori M . Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 2003; 169: 155\u2013158.","journal-title":"Atherosclerosis"},{"key":"BF1002310_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2337\/diacare.20.3.355","volume":"20","author":"AG Kontopoulos","year":"1997","unstructured":"Kontopoulos AG, Athyros VG, Didangelos TP . Effects of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diab Care 1997; 20: 355\u2013361.","journal-title":"Diab Care"},{"key":"BF1002310_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nuclcard.2005.11.009","volume":"13","author":"S Nagamachi","year":"2006","unstructured":"Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non\u2013insulin-dependent diabetes mellitus. J Nucl Cardiol 2006; 13: 34\u201342.","journal-title":"J Nucl Cardiol"},{"key":"BF1002310_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0165-6147(87)90201-X","volume":"8","author":"DF Story","year":"1987","unstructured":"Story DF, Ziogas J . Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol Sci 1987; 8: 269\u2013271.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1002310_CR23","first-page":"S13","volume":"20","author":"M Esler","year":"2002","unstructured":"Esler M . Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. J Hypertens 2002; 20: S13\u2013S19.","journal-title":"J Hypertens"},{"key":"BF1002310_CR24","first-page":"203","volume":"37","author":"KU Malik","year":"1978","unstructured":"Malik KU . Prostaglandins-modulation of adrenergic nervous system. Fed Proc 1978; 37: 203\u2013207.","journal-title":"Fed Proc"},{"key":"BF1002310_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2796.1991.tb00390.x","volume":"229","author":"A Schmidt","year":"1991","unstructured":"Schmidt A, Grossmann G, Hauner H, Koenig W, Jansen T, Stauch M et al. Left ventricular function and wall thickness in long-term insulin-dependent diabetes mellitus: an echocardiographic study. J Int Med 1991; 229: 527\u2013531.","journal-title":"J Int Med"},{"key":"BF1002310_CR26","first-page":"507","volume":"11","author":"B Waeber","year":"1989","unstructured":"Waeber B, Nussberger J, Perret L, Santoni JP, Brunner HR . Experience with perindopril in normal volunteers. Clin Exp Hypertens A 1989; 11: 507\u2013519.","journal-title":"Clin Exp Hypertens A"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1002310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1002310","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1002310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:12:29Z","timestamp":1647547949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1002310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,29]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF1002310"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1002310","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,29]]},"assertion":[{"value":"27 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}